Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 99351-99400 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04652076
GYNecological Cancers Treated with NETrin MAbs in Combination with Chemotherapy and /or Pembrolizumab
PHASE1/PHASE2Active, not recruiting
240 participants
Started: Dec 14, 2020 · Completed: Jul 30, 2026
2 conditions3 sponsors15 locations
NCT03969953
Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease
PHASE3Recruiting
2,000 participants
Started: Dec 14, 2020 · Completed: Dec 31, 2027
3 conditions5 sponsors91 locations
NCT04987099
Effects of Increased Maternal Choline Intake on Child Cognitive Development
NAActive, not recruiting
40 participants
Started: Dec 13, 2020 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT04657068
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
PHASE1/PHASE2Recruiting
502 participants
Started: Dec 13, 2020 · Completed: Dec 31, 2026
9 conditions1 sponsor71 locations
NCT04843501
Middle School Cluster Randomized Controlled Trial (RCT) to Evaluate E-Cigarette Prevention Program: CATCH My Breath
NAActive, not recruiting
1,790 participants
Started: Dec 13, 2020 · Completed: Dec 1, 2024
1 condition2 sponsors1 location
NCT04338399
The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC
PHASE3Active, not recruiting
483 participants
Started: Dec 12, 2020 · Completed: Jun 30, 2026
1 condition1 sponsor162 locations
NCT04875078
UVA-1 for Treatment of Skin Tightening and Improvement of Hand Function in Scleroderma
NAEnrolling by invitation
30 participants
Started: Dec 12, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04678635
Chronic Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies
NARecruiting
40 participants
Started: Dec 12, 2020 · Completed: Dec 4, 2024
1 condition1 sponsor1 location
NCT04452955
A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients with Solid Tumors
PHASE2Active, not recruiting
51 participants
Started: Dec 12, 2020 · Completed: Dec 1, 2025
1 condition2 sponsors5 locations
NCT04342546
Predictive Toxicity Test Linked to Radiotherapy After Mastectomy and Immediate Implant Reconstruction
NARecruiting
250 participants
Started: Dec 11, 2020 · Completed: Jun 30, 2027
2 conditions1 sponsor9 locations
NCT05673902
Study of the Safety and Efficacy of RPH-104 in Preventing Recurrences in Patients With Idiopathic Recurrent Pericarditis
PHASE3Active, not recruiting
17 participants
Started: Dec 11, 2020 · Completed: Jan 31, 2026
1 condition5 sponsors1 location
NCT04573478
Atrasentan in Patients With IgA Nephropathy
PHASE3Active, not recruiting
404 participants
Started: Dec 11, 2020 · Completed: Dec 18, 2026
2 conditions1 sponsor135 locations
NCT04635995
Phase 1 Trial of LVGN7409 (CD40 Agonist Antibody) as Single Agent and Combination Therapies in Advanced or Metastatic Malignancy
PHASE1Active, not recruiting
126 participants
Started: Dec 11, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04333823
Adolescent Type 1 Diabetes Treatment With SGLT2i for hyperglycEMia & hyPerfilTration Trial
PHASE3Active, not recruiting
100 participants
Started: Dec 11, 2020 · Completed: May 31, 2024
1 condition3 sponsors3 locations
NCT04666103
Function Integrity of Neck Anatomy in Thyroid Surgery
NARecruiting
1,264 participants
Started: Dec 11, 2020 · Completed: Dec 12, 2026
3 conditions1 sponsor1 location
NCT04659317
Opioid-Free Orthopaedics
PHASE3Recruiting
80 participants
Started: Dec 11, 2020 · Completed: Dec 31, 2028
2 conditions1 sponsor3 locations
NCT04198922
Acalabrutinib for the Treatment of Chronic Graft Versus Host Disease
PHASE2Active, not recruiting
51 participants
Started: Dec 11, 2020 · Completed: Apr 30, 2027
2 conditions2 sponsors6 locations
NCT04665882
Nomogram to Predict Breast Cancer Related Lymphedema
NARecruiting
600 participants
Started: Dec 11, 2020 · Completed: Dec 31, 2027
4 conditions1 sponsor1 location
NCT04258449
DOvEEgene Fleur: New Uterine Sampling Tool
N/ARecruiting
40 participants
Started: Dec 11, 2020 · Completed: Oct 1, 2026
1 condition3 sponsors1 location
NCT05438069
German Inclisiran Network: Retrospective Registry of Patients Being Treated With the siRNA Inclisiran in Germany
N/ARecruiting
500 participants
Started: Dec 11, 2020 · Completed: Dec 11, 2025
1 condition9 sponsors1 location
NCT04537689
Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis
PHASE4Recruiting
40 participants
Started: Dec 10, 2020 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT04579211
Prospective Analysis of Urine LAM to Eliminate NTM Sputum Screening
N/AEnrolling by invitation
220 participants
Started: Dec 10, 2020 · Completed: May 1, 2026
1 condition1 sponsor1 location
NCT04511572
Embolization of Middle Meningeal Artery in Chronic Subdural Hematoma
NARecruiting
170 participants
Started: Dec 10, 2020 · Completed: Oct 1, 2025
1 condition1 sponsor1 location
NCT04588545
Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease
PHASE1/PHASE2Recruiting
39 participants
Started: Dec 10, 2020 · Completed: Aug 31, 2026
3 conditions2 sponsors2 locations
NCT04604314
Alternative EndoCrowns Designs for Chairside CAD/CAM
NAActive, not recruiting
69 participants
Started: Dec 10, 2020 · Completed: Dec 1, 2027
1 condition2 sponsors1 location
NCT04659434
Sintilimab Plus R-GemOx as Second-line Salvage Therapy in Patients With R/R DLBCL
PHASE2Not yet recruiting
51 participants
Started: Dec 10, 2020 · Completed: Dec 10, 2025
3 conditions1 sponsor1 location
NCT04701671
Project THINK: Trajectories of Health, Ingestive Behaviors, and Neurocognition in Kids
N/ARecruiting
180 participants
Started: Dec 10, 2020 · Completed: Dec 9, 2025
2 conditions4 sponsors2 locations
NCT04684940
Safety, Tolerability, and Efficacy Study of Valoctocogene Roxaparvovec in Hemophilia A With Active or Prior Inhibitors
PHASE1/PHASE2Active, not recruiting
10 participants
Started: Dec 10, 2020 · Completed: Apr 30, 2029
2 conditions1 sponsor9 locations
NCT04543591
Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant
PHASE3Active, not recruiting
148 participants
Started: Dec 10, 2020 · Completed: Mar 20, 2026
1 condition1 sponsor67 locations
NCT04654260
Behavior Therapy for Irritability in Autism
NAActive, not recruiting
65 participants
Started: Dec 10, 2020 · Completed: Feb 28, 2026
7 conditions2 sponsors1 location
NCT04663204
A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A Nephropathy
PHASE2Active, not recruiting
12 participants
Started: Dec 10, 2020 · Completed: Mar 31, 2025
6 conditions2 sponsors5 locations
NCT05833997
Safety Analysis and Oncological Outcomes in HoLERT vs TURBT
NARecruiting
100 participants
Started: Dec 10, 2020 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT04225520
AMEND-CRT: Mechanical Dyssynchrony as Selection Criterion for CRT
NARecruiting
700 participants
Started: Dec 10, 2020 · Completed: Dec 1, 2030
4 conditions1 sponsor24 locations
NCT04907396
International Weight Control Registry
N/ARecruiting
100,000 participants
Started: Dec 10, 2020 · Completed: Dec 1, 2025
3 conditions7 sponsors7 locations
NCT04295447
Adjuvant Apalutamide in Subjects With High-risk Localized or Locally Advanced Prostate Cancer After Radical Prostatectomy
PHASE2Active, not recruiting
190 participants
Started: Dec 10, 2020 · Completed: Nov 30, 2028
1 condition2 sponsors21 locations
NCT03549910
A Multicenter, Random Control Study :Early Use of Airway Pressure Release Ventilation (APRVplus) Protocol in ARDS
NARecruiting
840 participants
Started: Dec 10, 2020 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT06462001
BCG + MMC: Adding Mitomycin C to BCG in High-risk, Non-muscle-invasive Bladder Cancer
PHASE3Active, not recruiting
500 participants
Started: Dec 10, 2020 · Completed: Dec 1, 2026
2 conditions3 sponsors1 location
NCT05029258
Biomarkers for Clinical Hypoxia Evaluation in Cervical Cancer
N/ARecruiting
30 participants
Started: Dec 10, 2020 · Completed: Oct 31, 2027
1 condition2 sponsors1 location
NCT04677790
Gradual Egg-tolerance Induction in Hen's Egg Allergic Children Who Tolerate Baked Egg (TETI-II Study)
NAActive, not recruiting
62 participants
Started: Dec 9, 2020 · Completed: Dec 31, 2024
1 condition3 sponsors4 locations
NCT04652882
Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)
PHASE3Recruiting
70 participants
Started: Dec 9, 2020 · Completed: Dec 31, 2025
3 conditions1 sponsor21 locations
NCT04258475
The Influence of Concurrent Oral Calcium Carbonate Supplementation on Steady State Pharmacokinetics of Oral Raltegravir.
PHASE4Recruiting
12 participants
Started: Dec 9, 2020 · Completed: Jan 1, 2025
1 condition1 sponsor1 location
NCT04436731
Sex Disparities in Hypoxic Sympatholysis and Impact of Obesity
EARLY_PHASE1Active, not recruiting
104 participants
Started: Dec 9, 2020 · Completed: Jun 30, 2026
4 conditions1 sponsor1 location
NCT04729686
The Pericapsular Nerve Block in Total Hip Arthroplasty
PHASE4Recruiting
78 participants
Started: Dec 9, 2020 · Completed: Dec 1, 2025
2 conditions2 sponsors1 location
NCT04317677
Effects of Bladder Voiding on Sleep Architecture in Infants
NARecruiting
30 participants
Started: Dec 9, 2020 · Completed: Dec 9, 2025
1 condition1 sponsor1 location
NCT04582825
Stroke-Card Registry
N/ARecruiting
5,000 participants
Started: Dec 9, 2020 · Completed: Jul 31, 2027
2 conditions3 sponsors2 locations
NCT04499053
Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer
PHASE2Recruiting
18 participants
Started: Dec 9, 2020 · Completed: Dec 31, 2027
1 condition2 sponsors4 locations
NCT04682145
Adverse Event Data Collection From the EUHASS Registry on Turoctocog Alfa Pegol
N/AEnrolling by invitation
50 participants
Started: Dec 9, 2020 · Completed: Feb 1, 2026
1 condition1 sponsor1 location
NCT04261829
AFT: Introduction of a Full Breast Reconstructive Method
N/ARecruiting
350 participants
Started: Dec 9, 2020 · Completed: Oct 31, 2026
3 conditions2 sponsors8 locations
NCT04257929
A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension
PHASE2Active, not recruiting
65 participants
Started: Dec 9, 2020 · Completed: Sep 7, 2028
1 condition1 sponsor13 locations
NCT04234646
Patient Navigation 2.0
NAActive, not recruiting
600 participants
Started: Dec 9, 2020 · Completed: Dec 31, 2025
1 condition2 sponsors1 location